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Race and the risk of peritonitis: An analysis of factors associated with
the initial episode. To study how clinical characteristics influence the risk
of peritonitis in African American patients with end-stage renal disease
treated with continuous ambulatory peritoneal dialysis (CAPD), we
examined the risk of developing a first episode of peritonitis among 1,595
new dialysis patients initially treated by CAPD over a two year period in
North Carolina, South Carolina, and Georgia (Network 6). Characteristics
examined were demographic and socioeconomic factors, functional status,
serum albumin and comorbid conditions. There were 538 initial episodes
of peTitonitis during an average of 8.8 patient months of follow-up; the
time to peritonitis for the entire cohort was 26 months. Factors found to
be independently associated with a risk for peritonitis were student status
(Odds Ratio and 95% Confidence Interval = 2.4; 1.4 to 4.3), rental
housing (1.2; 1.0 to 1.5), and substance abuse (1.9; 1.1 to 3.2). African
Americans were 60% more likely to have an initial episode of peritonitis
during follow-up than whites (1.6; 1.3 to 1.8). The time to the initial
episode was 21 months for African Americans versus 32 months for whites
(P < 0.001). Even after adjusting for other factors, African Americans
were significantly more likely to develop peritonitis (1.5; 1.2 to 1.8). Thus,
the increased risk of peritonitis of African American patients treated by
CAPD is independent of other demographic, socioeconomic and comor-
bid characteristics.
Peritonitis is a common complication of continuous ambulatory
peritoneal dialysis (CAPD) but rates of peritonitis are not uni-
form among CAPD patients. A study of 5,984 African-American
and white CAPD patients between 1980 and 1984 found that age,
race, and cause of renal failure were independent risk factors for
developing peritonitis [1]. To avoid the complicating influence of
repeated bouts of peritonitis, the United States Renal Data
System (USRDS) studied factors influencing the first bout of
peritonitis during a 21 month period and found that compared to
whites, African-Americans were 61% more likely to develop
peritonitis after controlling for age, gender, cause of end-stage
renal disease (ESRD), CAPD program size, and ESRD treatment
prior to CAPD [2]. This analysis did not evaluate patient charac-
teristics such as socioeconomic status, comorbidity, and severity of
illness. If specific factors were found to be associated with an
increased risk of peritonitis, it might be possible to intervene to
reduce the frequency of peritonitis. This might increase the use of
CAPD as a treatment modality.
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Our purpose was to assess factors affecting the risk of perito-
nitis in CAPD patients. We studied the relationship between
demographic and socioeconomic factors, functional and nutri-
tional status, as well as comorbid conditions and the risk of
peritonitis in all new dialysis patients in Network 6 treated by
CAPD between 1990 and 1991. We chose to study only patients
who began treatment with CAPD because hemodialysis patients
who switch to PD appear to have a higher risk of peritonitis [1, 2].
We also chose to study only factors associated with the initial bout
of peritonitis to avoid biases resulting from differences in treat-
ment regimens or definitions of relapse vs reinfection.
Methods
We gathered information from the Network 6 Regional ESRD
Registry which routinely collects data on the occurrence of disease
and outcomes of treatment for all patients with ESRD in the
states of North Carolina, South Carolina and Georgia. All adult
patients 20 years and older whose first method of treatment was
CAPD (within 3 months of beginning ESRD therapy) and who
began treatment between January 1, 1990 and December 31, 1991
were eligible for study.
Patient characteristics were collected from the dialysis record
by facility staff and reported to the Network Registry within two
months of beginning treatment for ESRD. Demographic infor-
mation collected included age, sex, race (African-American or
white) and cause of renal failure (coded as diabetes or other for
the analyses). Socioeconomic factors analyzed included years of
formal education, student status, housing ownership, living ar-
rangements (alone, with family or others) and employment status.
Nutritional status was assessed by serum albumin level and
functional status was graded by the facility staff using a modified
Karnofsky Performance Scale [3]. The presence or absence of
fourteen comorbid factors was ascertained for each patient. These
comorbid factors included hypertension, comorbid diabetes (pa-
tients with diabetes but whose primary cause of ESRD was not
diabetes), peripheral vascular disease, congestive heart failure,
myocardial infarction, angina pectoris, cancer, blindness, periph-
eral neuropathy, clinical depression, renal osteodystrophy, smok-
ing, and alcohol and intravenous drug abuse.
Follow-up time for each patient was the interval from the first
day of CAPD until one of the following events occurred: perito-
nitis; death; loss to follow-up; change of treatment modality; or
the end of the study period on June 30, 1992. Peritonitis episodes
were reported by the treatment facility on a bimonthly census
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form. The time to the first peritonitis episode was calculated as
the number of months from the start of CAPD to the midpoint of
the two month interval in which the first episode was reported.
Peritonitis was diagnosed according to guidelines established at
each facility. Peritonitis rates for subgroups of patients were
calculated by dividing the number of first episodes occurring in
the subgroup by the total follow up time for all patients in the
group. We report the reciprocal of this rate as the time in months
to the initial episode of peritonitis [2].
The association between a risk factor and risk of peritonitis was
estimated by the ratio of peritonitis rates for the groups with and
without the risk factor and expressed as the relative risk (RR) [4].
A 95% confidence interval was calculated for each RR and the
association was considered significant if the confidence interval
did not include 1. Life table analysis [5] as implemented in BMDP
(1L) computer software [6] was used to examine peritonitis-free
time in different cohorts. Differences in peritonitis-free time
between patient subgroups were assessed using statistics devel-
oped by Tarone and Ware [7]. Cox regression analysis (BMDP 2L
procedure [6]) was used to identify factors which were indepen-
dently associated with the first episode of peritonitis [8].
Results
There were 1,977 patients who began treatment by CAPD
during 1990 and 1991 in Network 6. We excluded 63 children who
were less than 20 years of age, 34 patients whose date of first
episode of peritonitis could not be ascertained from the records,
and 285 patients who were initially treated with hemodialysis for
more than 90 days before beginning CAPD. The mean age (± SD)
of the remaining 1,595 CAPD patients was 52.6 15 years; 868
were male and 44% were African-American.
There were 538 episodes of first peritonitis during the 30
months of follow-up affecting 33.7% of the cohort. Table 1 shows
the patient characteristics that were significantly associated with
the initial episode of peritonitis in the univariate analyses. Afri-
can-Americans were 60% (RR = 1.6) more likely than whites to
develop peritonitis. The time to an initial episode of peritonitis
was 21 months for African-American and 32 months for white
patients (P C 0.001).
Most of the patients owned their own home and 76% were
unemployed (Table 1). Housing status was associated with the
first episode of peritonitis: individuals who owned their homes
developed peritonitis later (29 months) than those who had
previously owned a home (26 months), rented (20 months), lived
in subsidized housing (23.4 months), or lived in other types of
housing (21 months). The time to peritonitis for patients who
were employed was 30% longer than that of those not working (P
< 0.05). Students had the shortest time to first episode of
peritonitis (10 months), compared to 26 months for nonstudents
(P C 0.01).
The prevalence of comorbid conditions ranged from 1% for
drug abuse to 69% for hypertension. Only two comorbid condi-
tions were significantly associated with the risk of peritonitis
(Table 1). Substance abuse more than doubled the risk of
peritonitis; the estimated time to develop peritonitis for these
patients was 14 months shorter than for other patients. The risk of
peritonitis was slightly higher among hypertensive patients than
non-hypertensives (P =03), but it was not significantly altered by
the presence of any of the remaining comorbid conditions (Table
2).
Table 1. Characteristics of 1,595 new CAPD patients associated with
the risk of peritonitis
Characteristic N %
Time to first
episode
months
Relative risk of
peritonitis
Race
White 889 56 32.3 —
African-American 706 44 20.7 1.6 (1.3—1.8)"
Studenta
No 1,361 98 26.4 —
Yes 23 2 10.1 2.6 (1.5-4.6)"
Employmcnta
No 1,058 76 25.2 —
Yes 326 24 29.9 0.8 (0.6_1.0)C
Housing
Owns home 1,083 68 29.2 —
Previous owner
Rents
13
241
1
15
26.5
20.5
1.1 (0.4—2.9)
1.4 (1.11.8)"
Subsidized
Other
86
172
5
11
23.4
20.8
1.2 (0.9—1.8)
1.4 (1.1—1.8)"
Hypertension
No 498 31 30.0 —
Yes 1,097 69 24.6 1.2 (1.0_1.5)C
Substance abuse
No 1,572 99 26.5 —
Yes 23 1 12.2 2.2 (1.3—3.7)"
95% Confidence Intervals of relative risk are in parentheses. — denotes
reference group to which other rates were compared.
aPatients do not total to 1,595 due to missing information
bp < 0.01P  0.05
Patients who were under 45 years of age or age 65 or older were
at somewhat higher risk for developing peritonitis than middle-
age patients but the differences did not reach statistical signifi-
cance (Table 2). The risk of developing peritonitis was not
associated with living with family members compared to living
alone. Although having other types of support (visiting nurse or
other caretakers) decreased the time to first episode to 22 months,
this interval was not significantly shorter than that of persons
living alone (26.6 months). There was no association between the
development of peritonitis and cause of ESRD, albumin level,
functional status, or education level (Table 2).
A life table analysis of peritonitis-free time showed that 64% of
patients were still being treated by peritoneal dialysis without
developing peritonitis after one year (Fig. 1). After 19 months (sn
1 month), 50% of the patients either developed peritonitis or were
withdrawn from the analysis because of some other censoring
event.
The peritonitis-free time varied between race-gender groups
(Fig. 2). The median (se) peritonitis-free time for white males was
23 (± 3) months; white females, 24 (±2) months; African-
American males, 16 (± 1) months; and, African-American fe-
males, 14 (± 1) months. Analyses examining peritonitis-free time
by race and gender separately showed that the differences were
significant for race (P C 0.001) but not gender (P = 0.5).
After controlling for the joint effects of factors found in the
univariate analyses to be associated with increased peritonitis risk,
race remained an independent risk factor for developing perito-
nitis (Table 3). African-Americans were 50% more likely than
whites to develop peritonitis (RR = 1.5; 95% CI = 1.3 to 1.8).
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— Denotes reference group to which other rates are compared.
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Fig. 1. Life table analysis of peritonitis-free time for 1,595 new chronic
ambulatoiy peritoneal dialysis patients in North Camlina, South Carolina,
and Geo,'iq, Janua,y 1, 1990 to June 30, 1992.
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Fig. 2. Lfe table analysis of peritonitis-free time among race-sex groups in
the 1,595 new CAPD patients studied. The differences in peritonitis-free
time were statistically significant for race (P < 0,01), but not gender (P —
0.5). Symbols are: white male ( ); white female ( ); black
male (— — —); black female (— — — —.).
Table 2. Characteristics of 1,595 new CAPD patients not associated
with the risk of peritonitis
1
0.8
0.6
0.4
0.2
Characteristic N %
Time to first
episode
months
Relative risk
of peritonitis
Age level years
<45 540 34 25.9 1,1 (0.9—1.3)
45—64 663 42 27.4 —
65+ 392 24 24.1 1.1 (0.9—1.4)
Gender
Female 727 46 26.6 —
Male 868 54 25.6 1.0(0.9—1.2)
Cause of ESRD
Other 1,017 64 27.1 —
Diabetes 578 36 24.3 1.1 (0.9—1.3)
Albumin level g/dla
 3.5 675 53 25.7 —
<3.5 609 47 25.2 1.0(0.8—1.2)
Functional statusa
Normal 215 17 27.3 —
Mildly impaired 607 47 25.3 1.1 (0.8—1.4)
Moderately impaired 328 25 24.0 1.1 (0.9—1.5)
Severely impaired 151 11 26.6 1.0 (0.7—1.5)
Education yearsa
0—8 214 16 25.8 —
9—12 716 53 24.6 1.0(0.8—1.4)
12+ 418 31 26.2 1.0 (0.7—1.3)
Social support
Lived alone 359 22 26.6 —
Lived with family 1,047 66 26.8 1.0 (0.8—1.2)
Lived with others 189 12 21.7 1.2 (0.9—1.7)
Alcoholism 73 5 20.0 1.3 (0.9—1.9)
Angina 200 13 27.5 0.9 (0.7—1.2)
Blindness 87 5 31.5 0.8 (0.5—1.2)
Cancer 45 3 18.5 1,4 (0.9—2.3)
Congestive heart failure 303 19 23.5 1.1 (0.9—1.4)
Depression
Comorbid diabetes'
289
99
18
6
25.3
24.8
1.0(0.8—1.3)
1.1 (0.8—1.5)
Myocardial infarction 157 10 22.2 1.2 (0.9—1.6)
Peripheral neuropathy 293 18 23.9 1.1 (0.9—1.4)
Peripheral vascular 288 18 26.0 1.0 (0.8—1.2)
disease
Renal osteodystrophy 50 3 28.1 0.9 (0.6—1.5)
Smoking 213 13 22.4 1.2 (0.9—1.5)
95% Confidence intervals of the relative risk are in parentheses.
0 6 12 18 24 30 36
Time, months
0.8
0.6
0.4
0.2
0 6 12 18 24 30 36
Time, months
Discussion
In a cohort of new CAPD patients, we found that African-
Americans had a 50% greater risk of developing peritonitis than
whites even after adjusting for several socioeconomic and comor-
bid factors that were independently associated with a higher risk
of peritonitis including living in rental housing, being a student,
and substance abuse.
Factors besides race which others have reported to be associ-
ated with peritonitis in national studies include age, gender, social
support, primary cause of and previous treatment of ESRD [1, 21.
Although we found similar trends, we did not observe a signifi-
cantly higher risk of developing peritonitis among older and
younger patients compared to middle aged patients. The smaller
size of our cohort may have resulted in inadequate power to
detect this relatively weak association. Our findings regarding
diabetes are consistent with those of Holley, Bernardini and
Piraino [9], who found no difference in the time to first infection
between 60 diabetic and 60 nondiabetic patients matched on
gender, mode [CAPD or continuous cycling peritoneal dialysis
(CCPD)], and type of catheter connector.
A number of other local studies have reported racial differences
in peritonitis rates. Holley, Bernardini and Piraino [10] examined
the rates of peritonitis in 68 African-American patients and 68
white patients matched on age, gender, insulin dependence, time
on dialysis, and mode of dialysis (CAPD vs. CCPD). Although
higher peritonitis rates were reported among African-American
patients, the potential influence of other socioeconomic or comor-
bid conditions was not examined. Korbet, Vonesh and Firanek
[11] reported that peritonitis rates among 146 patients treated in
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Table 3. Factors independently associated with the initial episode of
peritonitis determined by Cox regression analysis
Standard Relative risk
Factor Coefficient error of peritonitis
Race (African-American 0.4066 0.0935 1.5 (1.2—1.8)
vs. White)
Student 0.8937 0.2936 2.4 (1.4_4.3)a
Housing (rent vs. own) 0.2091 0.0944 1.2 (1.0_1.5)l
Substance abuse 0.6414 0.2730 1.9 (1.l_3.2)t
Analysis is limited to 1,384 patients for whom there was complete
information on all variables.
95% Confidence Intervals of the relative risk are in parentheses.
ap <0.01
bp < 0.05
their center were nearly two times higher among African-Amer-
ican patients than among white patients. Fewer years of formal
education were also associated with higher rates of peritonitis in
this center. Our results from 117 centers showed no association
with educational level. However, the racial differences in perito-
nitis rates found by Korbet et al were independent of education
level.
The higher risk of peritonitis that we observed among patients
who lived in rental housing or who used illicit drugs and the lower
risk among patients who were employed is consistent with obser-
vations by Sandroni and Moles [12]. Among 62 CAPD patients, 17
patients were identified as having a low rate (one episode per 9.5
months) and another 17 patients as having a high rate (one
episode per 2.5 months) of peritonitis. A higher proportion of
patients receiving public assistance and patients living in rental or
public housing were found in the high compared to the low
peritonitis rate group. While most patients who had worked two
years or longer at the same job were found in the low peritonitis
rate group, no patients who had a criminal record, abused drugs
or alcohol, or had a history of psychiatric problems requiring
referral had low peritonitis rates.
We can only speculate about possible explanations for these
associations. CAPD is a technically demanding procedure in
which inadvertant environmental contamination or lapses in
practice may increase the risk of peritonitis. It is reasonable to
suggest that individuals living in substandard housing or abusing
drugs might be more subject to these mishaps than others. Clearly
these issues deserve further study. However, none of these factors
appear to explain the greater risk of peritonitis among African-
American patients.
We recognize that the accuracy of our conclusions depends on
the diligence of the staff in each dialysis unit in completing the
forms accurately. We have no way of assessing whether dialysis
units that misclassify comorbid conditions also diagnose peritoni-
tis incorrectly. However, since the comorbid conditions were
identified at the onset of dialysis, their specification by facility staff
could not have been influenced by the subsequent development of
peritonitis. Inter-facility differences in diagnostic criteria for peri-
tonitis are of concern. A subsequent survey of facilities (75%
response rate) revealed that most centers (74%) used peritoneal
fluid white blood cell counts and culture results, either alone or in
combination with other signs including abdominal pain, cloudy
fluid, or fever, to establish the diagnosis. When we controlled for
this using the proportional hazard model, the relative risk of
peritonitis for African-American patients relative to whites was
unchanged (results not shown). While these data suggest that
differences in diagnostic criteria were unlikely to have produced
the racial differences that we observed, we cannot exclude this
possibility.
We do not think that the associations we found can be
explained by misclassification of either patient demographic or
treatment factors. Demographic and treatment data reported to
the ESRD Networks and the USRDS have been shown to closely
agree with that recorded in the patient record [13]. On the other
hand, we cannot exclude the misclassification of comorbid, func-
tional status, and socioeconomic factors examined in this study as
a possible explanation for some of the differences we found.
However, since the effect of race was equally strong both before
and after controlling for other patient characteristics, it is unlikely
that the racial differences in peritonitis rates could be fully
explained by better specification of these factors.
The increased risk of peritonitis that we observed among
African-American patients cannot be explained by differences in
patient selection or length of follow-up, since we studied all new
CAPD patients in a geographically defined population and our
follow-up was virtually complete. It is possible that episodes of
peritonitis for individual patients were not reported, but there is
no reason to believe that reporting errors would be more frequent
among African-Americans.
The intervals before the initial episode of peritonitis we ob-
served (21 months for African-Americans and 32 months for
whites) were much longer than those reported previously. Among
775 PD patients treated between 1979 and 1983, Nissenson et a!
[14] reported that 50% experienced at least one episode of
peritonitis during a 12 month period. The corresponding rates in
the present study were 34% and 23% for African-Americans and
whites, respectively. Nolph Ct al [1], using a life table analysis,
reported that 63% of the 8,829 PD patients entered into the
National CAPD Registry between 1980 and 1984 experienced an
episode of peritonitis within one year. Port et al [2] reported that
the time to the initial episode of peritonitis in 3,366 CAPD
patients starting treatment during the first half of 1989 ranged
from 11.4 months for patients using standard connection tech-
niques to 20.6 months for those using a Y-set. The 26 month
interval to the initial episode of peritonitis for all patients in the
present study is closer to the rates reported for peritoneal dialysis
patients outside of the U.S. and for patients participating in
controlled comparisons of the Y-set to other connection devices
[15—17]. Our findings suggest that peritonitis rates may be declin-
ing in the U.S.; perhaps this change is related to the increased use
of the Y-set connector since sales are rising for this device [18].
Because of limitations of the data gathered, we were unable to
control for characteristics of the treatment that might influence
the risk of peritonitis (for example, the method of catheter
connection) [19, 20]. It seems unlikely that differences in the use
of connectors among African-American and white patients were
responsible for our results for two reasons: first, it is unlikely that
CAPD centers would provide different techniques to African-
American and white patients; second, others find that race is an
independent risk factor for peritonitis even after adjustment for
connection technique [2], although this finding is not universal
[10].
It is possible that some, as yet unidentified biological difference
might influence the peritonitis risk among African-American
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patients. For example, there may be a greater risk for all
infections. Data from the USRDS reveal that African-American
PD patients with diabetic ESRD have a death rate from septice-
mia of 39 per 1000 patient years compared to 37.7 per 1000
patient years for whites [21]. The corresponding rates for non-
diabetics were 23 and 20.9 per 1000 patient years. Further study
will be required to evaluate whether there is an increased
susceptibility to infection.
In conclusion, we have found substantial variability in the
peritonitis rates among subgroups of new CAPD patients. Al-
though the rates in this cohort were lower than those previously
reported in U.S. populations, African-American CAPD patients
experienced a greater risk for peritonitis. Identification of the
cause of this discrepancy may lead to improvements which would
increase the use of this alternative therapy.
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